Phaserx Stock Revenue
| PZRXQDelisted Stock | USD 0.0002 0.00 0.00% |
PhaseRx fundamentals help investors to digest information that contributes to PhaseRx's financial success or failures. It also enables traders to predict the movement of PhaseRx Pink Sheet. The fundamental analysis module provides a way to measure PhaseRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PhaseRx pink sheet.
PhaseRx |
PhaseRx Company Revenue Analysis
PhaseRx's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, PhaseRx reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
PhaseRx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PhaseRx's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PhaseRx could also be used in its relative valuation, which is a method of valuing PhaseRx by comparing valuation metrics of similar companies.PhaseRx is currently under evaluation in revenue category among its peers.
PhaseRx Fundamentals
| Return On Equity | -2.28 | ||||
| Return On Asset | -0.64 | ||||
| Current Valuation | 199.2 K | ||||
| Shares Outstanding | 11.69 M | ||||
| Number Of Shares Shorted | 168.63 K | ||||
| Price To Book | 3.25 X | ||||
| EBITDA | (12.96 M) | ||||
| Net Income | (20.14 M) | ||||
| Cash And Equivalents | 5.26 M | ||||
| Cash Per Share | 0.45 X | ||||
| Total Debt | 5.13 M | ||||
| Current Ratio | 2.14 X | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (9.81 M) | ||||
| Short Ratio | 0.34 X | ||||
| Earnings Per Share | (1.19) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 10 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 30.39 K | ||||
| Total Asset | 16.45 M | ||||
| Net Asset | 16.45 M |
About PhaseRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PhaseRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PhaseRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PhaseRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with PhaseRx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PhaseRx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PhaseRx will appreciate offsetting losses from the drop in the long position's value.Moving against PhaseRx Pink Sheet
| 0.5 | DNLI | Denali Therapeutics | PairCorr |
| 0.38 | DOMH | Dominari Holdings | PairCorr |
| 0.37 | DSGN | Design Therapeutics | PairCorr |
| 0.33 | VERA | Vera Therapeutics | PairCorr |
The ability to find closely correlated positions to PhaseRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PhaseRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PhaseRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PhaseRx to buy it.
The correlation of PhaseRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PhaseRx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PhaseRx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PhaseRx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in PhaseRx Pink Sheet
If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |